INTRODUCTION
Esophageal cancer (EC) is a significant cause of morbidity and mortality worldwide and there is a growing body of evidence encompassing the pathological, clinical, oncological, radiological and basic science features of the disease. Advances in the global knowledge base continue apace and underpin developments that translate into improved treatments and patient survival.
The establishment of a citation rank list identifies published work that has had the greatest intellectual influence [1] . A citation is received when a publication is referenced by another peer-reviewed article and work that has the greatest impact on the scientific community is likely to be cited many times. Citation analysis involves ranking and evaluating an article or journal based on the number of citations it receives. In addition to determining the most frequently cited articles, this analysis is also used to rank journals in terms of impact [1] .
Many medical specialties have utilized the citation rank analysis to identify the most influential papers in their field which includes; trauma and orthopaedic surgery [2] , plastic surgery [3] , general surgery [4] and oncology [5] and gastric cancer [6] . To date, no study has been undertaken to determine the most influential papers in the field of esophageal cancer. Analysis of these data provides insight into how our understanding of esophageal cancer has developed and how this information has changed our management of the disease. The aim of this study was to determine the topics and specifically the studies that have been most influential related to the improved understanding and management of esophageal cancer.
METHODS

A search of the Thomson Reuters Web of Science citation indexing database and research
platform was completed using the search terms 'esophageal cancer' or 'esophageal carcinoma' or 'oesophageal cancer' or 'oesophageal carcinoma' or 'gastroscopy'. The returned dataset was filtered to include only English language and full manuscripts and sorted by number of citations; a method initially developed by Paladugu and colleagues [4] . The 100 most cited manuscripts were identified from the large number of manuscripts returned. The dataset was then further evaluated examining title, first and senior author, institution and department of the first author, topic, year of publication and the country of origin. The individual and 5 year impact factors (both for the year 2013) of each journal publishing the manuscripts were recorded.
RESULTS
The Web of Science search returned 121,556 full-length, English language papers. Table   1 lists the 100 most cited of these papers . The number of citations ranged from The 100 most influential papers were across 32 journals with the number of manuscripts per journal ranging from 1 to 15 (table 2) . Although Gastroenterology published the most papers (n=15 and 6362 citations), The New England Journal of Medicine (NEJM) had the most citations (n=12 and 12125 citations). The NEJM also had the highest impact factor (54.420) and 5-year impact factor (50.810).
The country with the greatest number of publications in the top 100 was the United States of America (USA) with 50 publications followed by Germany with 10 publications. The National Cancer Institute Bethesda had the highest amount of citations with 5081 and was the highest number of publications in the top 100 with 6 manuscripts (table 3). One author had 3 and 12 authors had 2 first author publications in the top 100.
A possible limitation of this type of study is that historical manuscripts may accrue a larger number of citations despite lacking the impact of newer publications. To control for this, the number of citations were divided by the number of years since publication to give a citation rate (table 4) [7, 8, 9, 10, 11, 12, 16, 27, 31, 76] The results of the current study confirm that these topics were highly represented with 87 manuscripts of the top 100 influential papers covering these areas.
Recently published manuscripts had a higher citation rate, which suggests a significant influence within the top 100 within the next 5 to 10 years.
Influential publications are more likely to be cited by the scientific community and these citations form the basis of the impact factor. The impact factor of a journal quantifies the average citations of the manuscripts published within the journal during a specific period. Therefore, journals with a higher impact factor are recognized as being of a higher quality and more likely to contain influential publications. Journals with very high impact factors (54.42 -29.35) ; NEJM, Lancet, JAMA and Nature Genetics only represent 17% of all publications in the top 100. Furthermore, the median impact factor was 15.69 and 18% of publications were in journals with an impact factor of 5.07 or less.
A possible explanation for this relates to the novelty of the results. Novelty can be classified as relating to science in general or only esophageal cancer. Findings that have already been established in other cancers may then be re-established in esophageal cancer. These manuscripts are unlikely to be published in high impact scientific journals, however, within the context of this study they are likely to be considered influential.
On review of the topics covered in the top 100, pathology and management of EC, specifically the influence of surgery and chemotherapy on prognosis, were well studied accounting for 87 manuscripts. The results of the MAGIC Trial [7] and the ToGA Trial [11] had the highest amount of citations and the highest citation rate respectively. The main limitation of this manuscript is the potential for several types of bias, which may affect results. Disproportionate citation may result from institutional bias, language biases, self citation or powerful person bias. In addition, older journals may receive more citations. Although an attempt to control for this was made by using the citation rate index, it may take a number of years for influential manuscripts to accrue citations due to the publication lead-time for their citing manuscript. Therefore, recently published manuscripts that have reached enough citations for inclusion in the top 100 have added importance. A further limitation is the inclusion of only first and senior authors and the institution of the first author. It is possible that several first authors will have co-authored other papers in the top 100 and are therefore under represented in the current study format. Finally, using a wildcard search term such as esoph* may have identified additional papers and this is also a relative weakness of this study.
CONCLUSION. The most cited manuscripts highlighted in this study describe the pathology, prognosis and management of EC including surgery and regimens that have resulted in the contemporary understanding and treatment of EC. Arguably, given the perceived relative lack of novelty to the science community in general, 40% of manuscripts were published in journals with impact factors of less than 10. In addition to providing a reference of what could be considered as the most influential papers in esophageal cancer, this work serves as a reference for researchers and clinicians alike as to the most popular research themes in esophageal cancer. This study also suggests that newer manuscripts have a higher citation rate, which will have a significant impact on the top 100 within the next 5 to10 years. 
